Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TIROFIBAN HYDROCHLORIDE
- Advancing Stroke Safety and Efficacy Through Early Tirofiban Administration After Intravenous Thrombolysis (ASSET-IT)
- Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)
- Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban
- Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke
- Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
- Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
- A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke
- One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In China
- Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke
- Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19
- Effect of Upstream High Bolus Dose of Tirofiban in Primary PCI for the Patients With STEMI on Short Term Outcome
- Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.
- Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention
- Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI
- Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI
- Tirofiban for Patients Treated With Alteplase
- Prolonged Enoxaparin In Primary Percutaneous Coronary Intervention; A Pilot Pharmacodynamic Study
- Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
- Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
- Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
- Intracoronary Tirofiban on No-Reflow Phenomena
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up
- Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
- On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
- Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary Syndrome
- The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
- Tirofiban in Stenting for Long Coronary Lesion
- Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
- Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
- Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients
- Aspirin Resistance and Percutaneous Coronary Intervention (PCI)
- Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction
- Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism
- Efficacy of Early Administration of Clotinab in Acute Myocardial Infarction
- Tirofiban and Enoxaparin in High Risk Coronary Intervention
- Shanghai Registry of Acute Coronary Events
- The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction
- Safety of High-dose Tirofiban During Coronary Angioplasty
- GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction
- Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation
- Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
- The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention
- Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance
- FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab
- PIoglitazone for PrEvention of Restenosis in Diabetic Patients
- Randomized Comparison of Abciximab Plus Heparin With Bivalirudin in Acute Coronary Syndrome
- Treating Acute MI Patients With Aggrastat on Their Way to Hospital
- Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
- Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis
Clinical trials list
click for details